Mark Slack

Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals.

McNeil Consumer Healthcare manufactures medicals products. It offers headache and muscle pain, arthritis pain, sinus, cold, flu, sleep and pain products as well as products for children and infants. The company is headquartered in Guelph, Canada.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Lucky Brand Dungarees LLC engages in the design, retail, and manufacture of denim and apparel. It offers denims, shirts, t-shirts and knits; shorts; pants; sweaters; jackets and hoodies; shoes, and accessories. The company was founded in 1990 and is headquartered in Los Angeles, CA.

Amoun Pharmaceutical Co. SAE manufactures and distributes human and veterinary pharmaceutical products and food supplements. The firm’s products include analgesics, anti-infectives, cardiovascular and gastrointestinal drugs and drugs for anesthesia, genito-urinary disorders, and respiratory systems. The company was founded by Sarwat Bassily in 1976 and is headquartered in Cairo, Egypt.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors.

MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.

Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.

ThirdLove, Inc. operates online clothing stores. It offers bras and underwear. The company was founded by David Spector and Heidi Zak in 2012 and is headquartered in San Francisco, CA.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Hound Labs, Inc. manufactures and wholesales scientific device to detect and measure the levels of both marijuana and alcohol in a person's breath. It specializes in detect and measure THC in breath, next generation marijuana breathalzyer, dual marijuana and alcohol breathalyzer and scientific research. The company was founded by Mike Lynn, Kuni Oh and Jenny Lynn in 2014 and is headquartered in Oakland, CA.

Satispay SpA operates a mobile payment application. It allows users to send money and pay in stores and online. The company was founded by Alberto Dalmasso, Dario Brignone, and Smauele Pinta in 2013 and is headquartered in Milan Italy.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

The Marshall Project, Inc. is a nonpartisan, nonprofit news organization that aims to raise awareness about the criminal justice system in the United States. The private company is based in New York, NY and was founded by Neil Steven Barsky. The company engages with individuals who have been impacted by the system and provide news coverage on the topic.

Intrinsic Capital Partners is a private equity/venture capital firm founded by Gerald Stahlecker, Cornelius Merlini, and Howard Goodwin. The firm is headquartered in Conshohocken, Pennsylvania.

LGT Impact Ventures (UK) (LGT Impact Ventures) is a private equity subsidiary of LGT Group Foundation founded in 2014. The firm is headquartered in London, United Kingdom.

Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million.

Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.

Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.

NextEvo, Inc. is a company that offers a range of fast-acting CBD products designed to promote wellness for both the body and mind. The company is based in Conshohocken, PA. John McDonagh has been the CEO of the company since 2020. The company's products are carefully created and include water-soluble CBD products that use their Smartsorb™ technology for better absorption. NextEvo Naturals is their premium line of pure CBD products.